Young people will have to wait until 2022 for coronavirus vaccine: WHO

0
3
Young people will have to wait until 2022 for coronavirus vaccine: WHO


The young people will have to wait until 2022 to receive a vaccine against him coronavirussaid today the authorities of the World Health Organization (WHO), who added that the priority in receiving the drug belongs to risk groups, among which are considered the elderly.


All sanitary measures were respected to take care of the health of the young people. (Daniel Barquet)


© Provided by Milenio
All sanitary measures were respected to take care of the health of the young people. (Daniel Barquet)


Although the WHO itself has clarified that “there is hope” of having an inoculation against covid-19, the truth is that today, Soumya Swaminathan, chief scientist of the international organization, clarified that these drugs have priority in the groups of the world population.

“People think that on January 1 there will be a vaccine and that things will go back to normal, but things will not be like that. No one has ever produced vaccines in the volumes that will be needed, so in 2021 we hope to have vaccines, but in a limited quantity. “

The agency also emphasized that there is a consensus that another sector of society to receive the vaccine first are health workers, who have had to face the pandemic on the front line, then the elderly and the most vulnerable people would pass.

“A young and healthy person will have to wait until 2022 to be vaccinated“said the scientist.

A dozen potential vaccines are currently in phase 3 clinical trials; In other words, they are being inoculated in groups of approximately 30 thousand people in places where the coronavirus continues to circulate intensely.

Video: There is no shortage of influenza vaccine, says the Ssa (Millennium)

There is no shortage of influenza vaccine, says the Ssa

This phase of clinical trials is used to verify the efficacy of the vaccine and to rule out serious side effects.

There are a total of forty vaccine trials, which are in one of the three phases of clinical trials. There are also another 200 that are in laboratory tests, circumstances that reveal the enormous pharmaceutical and biotechnological interest in finding the right formula.

“Until we have the results of phase 3 we will not know which and how many of those vaccines will be safeThey are effective and will protect for a long time, “Swaminathan said.

The representative of the WHO anticipated that these results could be ready at the beginning of next year, after which you will have to comply with the regulations for approval of one or more vaccines. However, they have also requested access to the results to all the institutions that are doing tests.

“Nothing should compromise the results that are obtained because these are vaccines that will be used in billions of people, so we need to be absolutely sure that it is the right decision,” Swaminathan said.

LEAVE A REPLY

Please enter your comment!
Please enter your name here